Ease Medical Apparatus And Instruments
Ease Medical Apparatus And Instruments
Advanced titanium alloy compression screws optimized for high-performance surgical environments.
As the "Medical Capital" of North Asia, Seoul represents a sophisticated market where surgical precision and technological adoption are paramount. With world-class institutions like Seoul National University Hospital and Asan Medical Center, the demand for high-end orthopedic implants—specifically cannulated screw implants—has seen a 15% CAGR over the last five years.
Our commitment as a leading exporter to the Seoul region is built on the E-E-A-T principle. We provide clinical-grade titanium hardware that meets the stringent requirements of the South Korean Ministry of Food and Drug Safety (MFDS) while offering significant information gain through our advanced manufacturing data and biocompatibility research.
In Seoul’s rapidly aging demographic, hip and femoral neck fractures have become a primary clinical focus. Cannulated screws, especially headless compression designs (Herbert type), allow for stable fixation with minimal soft tissue disruption, aligning perfectly with Seoul's shift toward Minimally Invasive Orthopedic Surgery (MIOS).
The global orthopedic supply chain is shifting. While traditional European brands maintain a presence, the "Quality-to-Value" ratio offered by our advanced Chinese manufacturing facility has become the preferred choice for major Seoul medical distributors.
| Feature | Our Manufacturing Standards | Clinical Benefit in Seoul Hospitals |
|---|---|---|
| Material Grade | Medical Grade 5 Titanium (Ti-6Al-4V ELI) | Superior Biocompatibility & MRI Compatibility |
| Production Precision | Swiss-type CNC Micro-machining (±0.005mm) | Exact Fit for Guide Wires, Reducing OR Time |
| Surface Treatment | Advanced Anodic Oxidation | Enhanced Fatigue Resistance & Easy Removal |
| Sterilization Compliance | ISO 13485 & CE MDR 2017/745 | Seamless Regulatory Approval in South Korea |
Supply Chain Efficiency: Located within the heart of China’s high-tech medical manufacturing cluster, we utilize a "Smart Factory" model. With 12 dedicated production lines and 36 QA/QC inspectors, we can fulfill large-scale orders for Seoul’s general hospitals within 14-21 days, compared to the 60-day lead times of Western competitors.
While titanium remains the gold standard, research into Magnesium-based biodegradable screws is rising in global R&D centers.
Seoul clinics are leaders in robotic surgery; our screws are designed with high radiopacity for fluoroscopic guidance.
Eliminating the need for pre-tapping reduces bone necrosis and surgical complexity, a key demand for trauma centers.
Complete range of headless compression and locking bone screws for complex trauma cases.
Founded in 2015, we have spent 10 years perfecting the metallurgy and mechanics of orthopedic fixation. Our 30,343㎡ facility is a testament to our manufacturing capacity, serving not only Seoul but also the Eastern European and Southeast Asian markets.
ISO 13485
Quality Management
CE MDR
European Compliance
MDSAP
Global Audit Standards
Our R&D team consists of 31 engineers, including 1 Doctorate and 11 Post-graduates, ensuring that every screw exported to South Korea exceeds ISO standards for pull-out strength, torque resistance, and surface purity.
Ready to upgrade your orthopedic inventory with world-class cannulated screws?
Send Inquiry NowThe core of our success in Seoul’s trauma centers lies in the thread pitch design. By utilizing a variable pitch technology, our screws generate interfragmentary compression as they are driven into the bone. This is critical for non-union prevention and promoting primary bone healing.
Furthermore, our cannulation process uses a unique "gun-drilling" technique that ensures perfect concentricity. For a 3.5mm screw, a 1.2mm guide wire must pass through with zero resistance. Any deviation in concentricity can lead to screw breakage or guide wire kinking during surgery—a risk our precision manufacturing eliminates.
As we look toward 2025, our focus remains on Surface Engineering. We are currently developing a new bioactive coating that further reduces the risk of infection, a top priority for South Korean health authorities in their "Smart Hospital" initiatives.
